{"name":"St. Anna Kinderkrebsforschung","slug":"st-anna-kinderkrebsforschung","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ATG Thymoglobulin","genericName":"ATG Thymoglobulin","slug":"atg-thymoglobulin","indication":"Kidney transplantation","status":"phase_2"},{"name":"Grafalon","genericName":"Grafalon","slug":"grafalon","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Fludarabine, OKT3, Treosulfan, Thiotepa","genericName":"Fludarabine, OKT3, Treosulfan, Thiotepa","slug":"fludarabine-okt3-treosulfan-thiotepa","indication":"Conditioning regimen prior to hematopoietic stem cell transplantation in pediatric leukemia and lymphoma","status":"phase_3"},{"name":"VP16, ATG","genericName":"VP16, ATG","slug":"vp16-atg","indication":"Small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"ATG Thymoglobulin","genericName":"ATG Thymoglobulin","slug":"atg-thymoglobulin","phase":"phase_2","mechanism":"T-cell depleting agent","indications":["Kidney transplantation","Bone marrow transplantation"],"catalyst":""},{"name":"Fludarabine, OKT3, Treosulfan, Thiotepa","genericName":"Fludarabine, OKT3, Treosulfan, Thiotepa","slug":"fludarabine-okt3-treosulfan-thiotepa","phase":"phase_3","mechanism":"This is a multi-drug conditioning regimen combining purine analog, T-cell depleting monoclonal antibody, and alkylating agents to suppress the immune system and ablate bone marrow prior to hematopoietic stem cell transplantation.","indications":["Conditioning regimen prior to hematopoietic stem cell transplantation in pediatric leukemia and lymphoma"],"catalyst":""},{"name":"Grafalon","genericName":"Grafalon","slug":"grafalon","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"VP16, ATG","genericName":"VP16, ATG","slug":"vp16-atg","phase":"phase_3","mechanism":"VP16 is an alkylating agent that works by cross-linking DNA, thereby inhibiting DNA replication and transcription.","indications":["Small cell lung cancer","Testicular cancer","Ovarian cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sak16UmdzalEzQ0doSzV0dmFFUXN3SGVHVTh4dkZ3Zy1zcy1uX25lWXV4Q2ROMVdOX2ZiS1poWDJrVE9lQTVLVVl1S2g4S0Q3UnJoUHdwc0NlU2lmQzl3?oc=5","date":"2023-10-10","type":"regulatory","source":"nature.com","summary":"Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 study | British Journal of Cancer - nature.com","headline":"Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, si","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_2":1,"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}